Status:
COMPLETED
A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)
Lead Sponsor:
Takeda
Conditions:
Inflammatory Bowel Diseases
Colitis, Ulcerative
Eligibility:
All Genders
18+ years
Brief Summary
The main aim of this study is to check the disease activity in people with moderate to severe ulcerative colitis and Crohn's disease. Participants will complete questionnaires about their disease and...
Detailed Description
This is a retrospective, cross-sectional, and non-interventional study of participants with moderate to severe IBD (UC or CD). The study will have a cross-sectional evaluation on Day 1 to provide the ...
Eligibility Criteria
Inclusion
- Diagnosed with moderate to severe CD or UC established for at least 6 months prior to Day 1 appointment, based on clinical, endoscopic or image criteria.
- Participants aged 18 years or older (at the time of diagnosis of moderate to severe UC or CD).
Exclusion
- Has indeterminate or not classified colitis.
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation.
Key Trial Info
Start Date :
August 30 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 17 2022
Estimated Enrollment :
335 Patients enrolled
Trial Details
Trial ID
NCT04873700
Start Date
August 30 2021
End Date
May 17 2022
Last Update
November 7 2024
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Unidad de Enfermedades Reumaticas y Cronico degenerativas
Torreón, Coahuila, Mexico, 27000
2
Centro De Investigacion Clinica De Alta Especialidad "Cicae"
Torreón, Coahuila, Mexico, 27010
3
Endoamer S.C.
Guadalajara, Jalisco, Mexico, 44600
4
CIMESAP Sociedad de Responsabilidad Limitada de Capital Variable
Zapopan, Jalisco, Mexico, 45138